Effect of eplerenone in percutaneous coronary intervention-treated post-myocardial infarction patients with left ventricular systolic dysfunction: a subanalysis of the EPHESUS trial

about

Effect of eplerenone in percutaneous coronary intervention-treated post-myocardial infarction patients with left ventricular systolic dysfunction: a subanalysis of the EPHESUS trial

Item

http://www.wikidata.org/entity/Q57985961

description

im April 2014 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у квітні 2014

@uk

name

Effect of eplerenone in percut ...... banalysis of the EPHESUS trial

@en

Effect of eplerenone in percut ...... banalysis of the EPHESUS trial

@nl

type

Item

label

Effect of eplerenone in percut ...... banalysis of the EPHESUS trial

@en

Effect of eplerenone in percut ...... banalysis of the EPHESUS trial

@nl

prefLabel

Effect of eplerenone in percut ...... banalysis of the EPHESUS trial

@en

Effect of eplerenone in percut ...... banalysis of the EPHESUS trial

@nl

P1476

Effect of eplerenone in percut ...... banalysis of the EPHESUS trial

@en

P2093

David Adlam

http://www.w3.org/2001/XMLSchema#string

Iain Squire

http://www.w3.org/2001/XMLSchema#string

Javaid Iqbal

http://www.w3.org/2001/XMLSchema#string

Julian Gunn

http://www.w3.org/2001/XMLSchema#string

Renaud Fay

http://www.w3.org/2001/XMLSchema#string

Yasir Parviz

http://www.w3.org/2001/XMLSchema#string

P2860

2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration

Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

Guidelines on myocardial revascularization.

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

Impairment of endothelial progenitor cell function and vascularization capacity by aldosterone in mice and humans.

Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease

Contribution of endogenous glucocorticoids and their intravascular metabolism by 11β-HSDs to postangioplasty neointimal proliferation in mice.

P304

685-691

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/EJHF.88

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Faiez Zannad

Bertram Pitt

P577

2014-04-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24706498

http://www.w3.org/2001/XMLSchema#string

P921

Aat atak

systole